The MRI-based quantitative biomarkers market is projected to grow from USD 326.5 million in 2025 to USD 536.9 million by 2035, advancing at a CAGR of 5.1%. Metabolic biomarkers are expected to lead the market with a 23.0% share in 2025, while diagnostic imaging centers are anticipated to account for the largest market share at 31.5%.